The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 4
  • 1
    Schipper, Rianne Caroline
    Investment Professional born in April 1991
    Individual (13 offsprings)
    Officer
    2017-05-26 ~ dissolved
    OF - Director → CIF 0
  • 2
    Behmoaram De Toledo, Cem
    Investment Professional born in February 1986
    Individual (5 offsprings)
    Officer
    2017-11-01 ~ dissolved
    OF - Director → CIF 0
  • 3
    Chen, Ruoxi
    Investment Professional born in October 1983
    Individual (5 offsprings)
    Officer
    2015-11-18 ~ dissolved
    OF - Director → CIF 0
  • 4
    45, Gresham Street, London, United Kingdom
    Dissolved Corporate (4 parents, 1 offspring)
    Equity (Company account)
    79,132,321 GBP2020-12-31
    Person with significant control
    2016-04-06 ~ dissolved
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Right to appoint or remove directors → CIF 0
Ceased 5
  • 1
    Shukla, Piyush Lalit
    Investment Professional born in January 1977
    Individual (9 offsprings)
    Officer
    2016-02-23 ~ 2017-02-01
    OF - Director → CIF 0
  • 2
    Meyers, Scott
    Ceo born in November 1975
    Individual
    Officer
    2020-09-08 ~ 2022-07-06
    OF - Director → CIF 0
  • 3
    Knauf, Noah
    Investment Professional born in January 1980
    Individual
    Officer
    2015-11-18 ~ 2016-07-08
    OF - Director → CIF 0
  • 4
    Degolyer, Don
    General Manager born in March 1961
    Individual
    Officer
    2015-11-18 ~ 2020-09-25
    OF - Director → CIF 0
    Degolyer, Don
    Individual
    Officer
    2015-11-18 ~ 2020-09-25
    OF - Secretary → CIF 0
  • 5
    Woolf, Anthony Charles
    Investment Professional born in December 1987
    Individual (2 offsprings)
    Officer
    2015-11-18 ~ 2016-02-23
    OF - Director → CIF 0
parent relation
Company in focus

VERTICE PHARMA UK FINANCE LIMITED

Standard Industrial Classification
64209 - Activities Of Other Holding Companies N.e.c.
Brief company account
Please be reminded the displayed account data is older than 4 years hence might not reflect current company status.
Administrative Expenses
-73,418 GBP2019-01-01 ~ 2019-12-31
-23,355 GBP2018-01-01 ~ 2018-12-31
Operating Profit/Loss
-73,418 GBP2019-01-01 ~ 2019-12-31
-23,355 GBP2018-01-01 ~ 2018-12-31
Profit/Loss
-73,418 GBP2019-01-01 ~ 2019-12-31
-42,560 GBP2018-01-01 ~ 2018-12-31
Debtors
253,335 GBP2019-12-31
253,335 GBP2018-12-31
Cash at bank and in hand
79,919 GBP2019-12-31
162,918 GBP2018-12-31
Current Assets
333,254 GBP2019-12-31
416,253 GBP2018-12-31
Creditors
Current, Amounts falling due within one year
-314,671 GBP2019-12-31
-324,252 GBP2018-12-31
Net Current Assets/Liabilities
18,583 GBP2019-12-31
92,001 GBP2018-12-31
Total Assets Less Current Liabilities
18,583 GBP2019-12-31
92,001 GBP2018-12-31
Net Assets/Liabilities
18,583 GBP2019-12-31
92,001 GBP2018-12-31
Equity
Called up share capital
1 GBP2019-12-31
1 GBP2018-12-31
1 GBP2018-01-01
Retained earnings (accumulated losses)
18,582 GBP2019-12-31
92,000 GBP2018-12-31
134,560 GBP2018-01-01
Equity
18,583 GBP2019-12-31
92,001 GBP2018-12-31
134,561 GBP2018-01-01
Profit/Loss
Retained earnings (accumulated losses)
-73,418 GBP2019-01-01 ~ 2019-12-31
-42,560 GBP2018-01-01 ~ 2018-12-31
Average Number of Employees
42019-01-01 ~ 2019-12-31
42018-01-01 ~ 2018-12-31
Deferred Tax Expense/Credit Relating to Origination/Reversal Timing Differences
19,205 GBP2018-01-01 ~ 2018-12-31
Profit/Loss on Ordinary Activities Before Tax
-73,418 GBP2019-01-01 ~ 2019-12-31
-23,355 GBP2018-01-01 ~ 2018-12-31
Tax Expense/Credit at Applicable Tax Rate
-13,949 GBP2019-01-01 ~ 2019-12-31
-4,437 GBP2018-01-01 ~ 2018-12-31
Amounts Owed by Group Undertakings
Current
253,335 GBP2019-12-31
253,335 GBP2018-12-31
Cash and Cash Equivalents
79,919 GBP2019-12-31
162,918 GBP2018-12-31
Amounts owed to group undertakings
Current
297,671 GBP2019-12-31
307,252 GBP2018-12-31
Accrued Liabilities/Deferred Income
Current
17,000 GBP2019-12-31
17,000 GBP2018-12-31
Creditors
Current
314,671 GBP2019-12-31
324,252 GBP2018-12-31
  • VERTICE PHARMA UK FINANCE LIMITED
    Info
    Registered number 09877986
    45 Gresham Street, London EC2V 7BG
    Private Limited Company incorporated on 2015-11-18 and dissolved on 2023-03-07 (7 years 3 months). The company status is Dissolved.
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.